MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today that it has completed a self-managed registered direct offering for $20 million of its common stock to two existing institutional investors. Under the terms of the transaction, Depomed has sold 5.3 million shares pursuant to its effective shelf registration statement at a price of $3.775 per share.
